(Q46054080)

19 December 2017

title

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13. (English)

1 reference

19 December 2017

0 references

0 references

2

1 reference

19 December 2017

Magdalena Lindén

object named as

M Lindén

1

0 references

Ingrid Kockum

object named as

I Kockum

6

0 references

Tommy Olsson

7

object named as

T Olsson

1 reference

19 December 2017

I Lima Bomfim

3

1 reference

19 December 2017

F Piehl

4

1 reference

19 December 2017

M Jagodic

5

1 reference

19 December 2017

publication date

22 November 2012

1 reference

19 December 2017

Multiple Sclerosis Journal

published in

1 reference

19 December 2017

volume

19

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

863-870

1 reference

19 December 2017

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Resolution of a 16.8-Mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyelitis quantitative trait loci and evidence for epistasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

SCAN: SNP and copy number annotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

seeQTL: a searchable database for human eQTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

RGMA and IL21R show association with experimental inflammation and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

The basic helix-loop-helix olig3 establishes the neural plate boundary of the trunk and is necessary for development of the dorsal spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512463482

21 January 2018

Identifiers

DOI

10.1177/1352458512463482

1 reference

19 December 2017

1 reference

19 December 2017